D8Ertd738e Inhibitors
Chemical inhibitors of D8Ertd738e employ a variety of mechanisms to impede its activity. Staurosporine, a broad-spectrum kinase inhibitor, can interrupt the phosphorylation process critical for the activation of numerous proteins, including D8Ertd738e if it functions as a kinase substrate. Similarly, LY294002 and Wortmannin both target the PI3K/AKT signaling pathway, a crucial pathway for cell survival and proliferation. By inhibiting PI3K, these chemicals can suppress the activity of D8Ertd738e if it requires PI3K/AKT pathway activation for its function. U0126 and PD98059 specifically inhibit MEK1/2, which is necessary for the activation of ERK in the MAPK pathway. If D8Ertd738e is regulated by this pathway, its activity would be impeded by these inhibitors. SB203580 and SP600125 target different components of the MAPK pathway, with SB203580 aiming at p38 MAPK and SP600125 inhibiting JNK. The inhibition of these kinases can lead to reduced activity of D8Ertd738e if it is influenced by stress responses or cytokine production mediated through p38 MAPK or is regulated by pathways involving JNK activity.
Further, PP2 and Bisindolylmaleimide I focus on the Src family kinases and PKC isoforms, respectively, which are key mediators in various signaling pathways, including those related to cell proliferation and survival. PP2's inhibition of Src kinases and Bisindolylmaleimide I's suppression of PKC activity can lead to the functional inhibition of D8Ertd738e if it is involved in signaling cascades controlled by these kinases. Rapamycin's inhibition of mTOR disrupts the mTOR signaling pathway, which can inhibit the activity of D8Ertd738e if it is a component of this pathway. Y-27632 inhibits ROCK kinase, which impacts cell shape and motility. If D8Ertd738e activity is linked to processes governed by Rho/ROCK signaling, its inhibition by Y-27632 can be anticipated. Lastly, Chelerythrine targets protein kinase C (PKC), a kinase involved in numerous signaling pathways; thus, if D8Ertd738e's action relies on PKC-mediated signaling, chelerythrine can inhibit its function. Each of these inhibitors can be instrumental in understanding the regulatory mechanisms and signaling pathways that govern the activity of D8Ertd738e.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Inhibition of these kinases can lead to reduced phosphorylation and activation of numerous proteins, thus functionally inhibiting D8Ertd738e if it is a substrate of these kinases. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 specifically inhibits PI3K, leading to a blockade of the PI3K/AKT signaling pathway. By preventing PI3K activity, the downstream effects, including the activity of D8Ertd738e, are inhibited if D8Ertd738e is functionally regulated by this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, enzymes upstream of ERK in the MAPK pathway. By inhibiting MEK, U0126 prevents the activation of ERK, thereby inhibiting the functional activity of D8Ertd738e if it is regulated by the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which is involved in stress responses and cytokine production. Inhibition of p38 MAPK can lead to functional inhibition of D8Ertd738e if this protein's activity is dependent on signals transduced by p38 MAPK. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases are involved in various signaling pathways, including those regulating cell proliferation and survival. Inhibition of Src kinases by PP2 can functionally inhibit D8Ertd738e if it is part of a pathway involving Src signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, similar to LY294002, which can inhibit the PI3K/AKT signaling pathway. By inhibiting PI3K, Wortmannin can functionally inhibit D8Ertd738e if the protein relies on PI3K/AKT signaling for its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the mTOR signaling pathway important for cell growth and proliferation. Inhibition of mTOR by Rapamycin can lead to functional inhibition of D8Ertd738e if it is part of the mTOR signaling cascade. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which prevents activation of ERK in the MAPK pathway. This inhibition can functionally inhibit D8Ertd738e if the protein's functional activity is dependent on the MAPK/ERK signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK pathway. Inhibition of JNK can functionally inhibit D8Ertd738e if the protein is regulated by signaling pathways that involve JNK activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK kinase, which influences cytoskeletal dynamics and cell morphology. Inhibition of ROCK by Y-27632 can functionally inhibit D8Ertd738e if it is involved in cellular processes regulated by Rho/ROCK signaling. | ||||||